Gel approved for KS.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000287:Administration, Topical; D000077556:Alitretinoin; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D005782:Gels; D006801:Humans; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D014212:Tretinoin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D005782:Gels; D000077556:Alitretinoin; D014212:Tretinoin